Allgemein – ARTES Biotechnology

Protected: Biosimilars

There is no excerpt because this is a protected post.

Head of Molecular Biology at ARTES

Features of ARTES´ Hansenula polymorpha protein production platform

Heterolougus production of holoproteins containing a co-factor and/or prosthetic group in Hansenula polymorpha – White Paper available

ARTES’ Proteins for Diagnostics

New Paper Published

ARTES 20th Year Anniversary – a short overview

Cellumed and ARTES Sign Development and License Agreement

VLP Purification Patent granted in US

ARTES is pleased to announce the enlargement of the protective aera for their VLP development and production platform patent . The patent is about a

“Method for Separating of Viruslike Particles from a Cell Suspension” and now valid in Europe and US.

VLP purification patent granted in EU

Artes is pleased to announce the issuance of a new patent for their VLP development and production platform. The patent is about a

“Method for Separating of Viruslike Particles from a Cell Suspension”.

ARTES and Burnet Institute publish data on new malaria vaccine candidates

For more information:

Novel Virus-Like Particle Vaccine Encoding the Circumsporozoite Protein of Plasmodium falciparum Is Immunogenic and Induces Functional Antibody Responses in Mice.